Articles
From Strategy to Launch, EVERSANA’s Regulatory Consulting Helps European Pharma Achieve U.S. Approval
Posted on December 8, 202312/8/23
How a Start-Up Developing an Innovative AI-Enabled Imaging Device Achieved FDA Clearance in 24 Months
Posted on December 8, 202312/8/23
Early-Stage Pharmaceutical Company Overcomes Development Hurdles with Expert Clinical and CMC Regulatory Support
Posted on December 8, 202312/8/23
EVERSANA’s Regulatory Consulting Saves Big for Virtual Manufacturer: Uncovers Non-Compliance, Excessive Costs, and Risks
Posted on December 8, 202312/8/23
Leveraging QMS and Regulatory Expertise to Support Tissue Compliance
Posted on October 20, 202310/20/23
Robust Signal Management to Achieve Patient Safety-Signal Case Study
Posted on October 3, 202310/3/23
Successful Implementation of End-To-End Pharmacovigilance Services For Drug-Device Combination Product Portfolio
Posted on October 3, 202310/3/23
FDA Inspection Win for Mid-Sized Pharma (50+ Products) with Extensive Generic Product Portfolio
Posted on October 3, 202310/3/23